The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat. [electronic resource]
Producer: 20130102Description: 349-56 p. digitalISSN:- 1096-1186
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Animals
- Benzimidazoles -- pharmacology
- Benzoates -- pharmacology
- Blood Glucose -- metabolism
- Creatine -- blood
- Diabetes Mellitus -- chemically induced
- Diabetic Nephropathies -- blood
- Drug Therapy, Combination
- Female
- Fenofibrate -- pharmacology
- Hypolipidemic Agents -- pharmacology
- Kidney -- drug effects
- Lipids -- blood
- Male
- Nitrogen -- blood
- Oxidative Stress -- drug effects
- PPAR alpha -- agonists
- Proteinuria -- prevention & control
- Rats
- Rats, Wistar
- Streptozocin
- Telmisartan
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.